| |
Centre for Policy on Ageing | |
 | |
|
Disease management
— who needs it and why? | | Author(s) | Michael Drummond |
| Corporate Author | Centre for Health Economics, University of York; York Health Economics Consortium; NHS Centre for Reviews and Dissemination |
| Publisher | University of York, York, 1997 |
| Pages | 19 pp (Centre for Health Economics discussion paper, 152) |
| Source | The Publications Office, Centre for Health Economics, University of York, York YO1 5DD. |
| Keywords | Drugs ; Medical care ; Management [care]. |
| Annotation | 'Disease management', the definition of which is imprecise, seems to encompass everything to do with the organisation and delivery of health care, and the effects of cost on diagnosis and treatment - including the pharmaceutical industry's involvement. This paper explores various ideas of 'disease management', assessing their usefulness to the pharmaceutical industry, the National Health Service (NHS), and society more generally. The main attributes of disease management activities are that they encourage consideration of the full costs of disease, the cost-effectiveness of alternative approaches to diagnosis and treatment, and the development of innovative approaches to the provision of care. However, they do not provide a prima facie case for the pharmaceutical industry to be more involved in management of patient care. The author concludes that an essential component of any disease management strategy should be a thorough examination of the costs and effectiveness of alternative health care treatments and programmes. |
| Accession Number | CPA-971007210 B |
| Classmark | LLD: LK: QA |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|